Large-scale testing (Phase 3)Looking for participantsNCT06056297
What this trial is testing
Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Who this might be right for
Neutropenia
X4 Pharmaceuticals 176